These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35866594)

  • 61. Down-regulation of miR-675-5p contributes to tumor progression and development by targeting pro-tumorigenic GPR55 in non-small cell lung cancer.
    He D; Wang J; Zhang C; Shan B; Deng X; Li B; Zhou Y; Chen W; Hong J; Gao Y; Chen Z; Duan C
    Mol Cancer; 2015 Apr; 14():73. PubMed ID: 25889562
    [TBL] [Abstract][Full Text] [Related]  

  • 62. MicroRNA-98 Plays a Suppressive Role in Non-Small Cell Lung Cancer Through Inhibition of SALL4 Protein Expression.
    Liu W; Xiao P; Wu H; Wang L; Kong D; Yu F
    Oncol Res; 2017 Jul; 25(6):975-988. PubMed ID: 27938506
    [TBL] [Abstract][Full Text] [Related]  

  • 63. MicroRNA‑92a promotes non‑small cell lung cancer cell growth by targeting tumor suppressor gene FBXW7.
    Ni D; Teng J; Cheng Y; Zhu Z; Zhuang B; Yang Z
    Mol Med Rep; 2020 Oct; 22(4):2817-2825. PubMed ID: 32945381
    [TBL] [Abstract][Full Text] [Related]  

  • 64. miR-203 inhibits cell proliferation, invasion, and migration of non-small-cell lung cancer by downregulating RGS17.
    Chi Y; Jin Q; Liu X; Xu L; He X; Shen Y; Zhou Q; Zhang J; Jin M
    Cancer Sci; 2017 Dec; 108(12):2366-2372. PubMed ID: 28921827
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CiRS-7 targeting miR-7 modulates the progression of non-small cell lung cancer in a manner dependent on NF-κB signalling.
    Su C; Han Y; Zhang H; Li Y; Yi L; Wang X; Zhou S; Yu D; Song X; Xiao N; Cao X; Liu Z
    J Cell Mol Med; 2018 Jun; 22(6):3097-3107. PubMed ID: 29532994
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
    Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
    Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Overexpression of miR-499-5p inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3.
    Li M; Zhang S; Wu N; Wu L; Wang C; Lin Y
    Sci Rep; 2016 Mar; 6():23100. PubMed ID: 26972445
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LncRNA SNHG16 promotes non-small cell lung cancer development through regulating EphA2 expression by sponging miR-520a-3p.
    Yu L; Chen D; Song J
    Thorac Cancer; 2020 Mar; 11(3):603-611. PubMed ID: 31953899
    [TBL] [Abstract][Full Text] [Related]  

  • 69. miRNA‑375 regulates the cell survival and apoptosis of human non‑small cell carcinoma by targeting HER2.
    Cheng L; Zhan B; Luo P; Wang B
    Mol Med Rep; 2017 Mar; 15(3):1387-1392. PubMed ID: 28098887
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p.
    Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H
    Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. MicroRNA-142-3p/MALAT1 inhibits lung cancer progression through repressing β-catenin expression.
    Liu J; Tian W; Zhang W; Jia Y; Yang X; Wang Y; Zhang J
    Biomed Pharmacother; 2019 Jun; 114():108847. PubMed ID: 30970294
    [TBL] [Abstract][Full Text] [Related]  

  • 72. MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase.
    Lei T; Zhu Y; Jiang C; Wang Y; Fu J; Fan Z; Qin H
    Mol Med Rep; 2016 Aug; 14(2):1255-62. PubMed ID: 27277534
    [TBL] [Abstract][Full Text] [Related]  

  • 73. microRNA-935 is reduced in non-small cell lung cancer tissue, is linked to poor outcome, and acts on signal transduction mediator E2F7 and the AKT pathway.
    Wang C; Li S; Xu J; Niu W; Li S
    Br J Biomed Sci; 2019 Jan; 76(1):17-23. PubMed ID: 30203720
    [TBL] [Abstract][Full Text] [Related]  

  • 74. miR-140-3p inhibits progression of non-small cell lung cancer by targeting Janus kinase 1.
    Hu C; Zou Y; Jing LL
    J Biosci; 2020; 45():. PubMed ID: 32345774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Exosomal miR-660-5p promotes tumor growth and metastasis in non-small cell lung cancer.
    Qi Y; Zha W; Zhang W
    J BUON; 2019; 24(2):599-607. PubMed ID: 31128012
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hsa-miR-329 exerts tumor suppressor function through down-regulation of MET in non-small cell lung cancer.
    Sun CC; Li SJ; Zhang F; Pan JY; Wang L; Yang CL; Xi YY; Li de J
    Oncotarget; 2016 Apr; 7(16):21510-26. PubMed ID: 26909600
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MicroRNA-7 inhibits the malignant phenotypes of non‑small cell lung cancer in vitro by targeting Pax6.
    Luo J; Li H; Zhang C
    Mol Med Rep; 2015 Oct; 12(4):5443-8. PubMed ID: 26135959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MicroRNA‑214 upregulates HIF‑1α and VEGF by targeting ING4 in lung cancer cells.
    Li Y; Zhao L; Qi Y; Yang X
    Mol Med Rep; 2019 Jun; 19(6):4935-4945. PubMed ID: 31059086
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LINC00184 plays an oncogenic role in non-small cell lung cancer via regulation of the miR-524-5p/HMGB2 axis.
    Wang W; Li L; Zhao L
    J Cell Mol Med; 2021 Nov; 25(21):9927-9938. PubMed ID: 34651416
    [TBL] [Abstract][Full Text] [Related]  

  • 80. PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.
    Xiong S; Zheng Y; Jiang P; Liu R; Liu X; Qian J; Gu J; Chang L; Ge D; Chu Y
    Br J Cancer; 2014 Jan; 110(2):353-62. PubMed ID: 24281003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.